In the healthcare sector, the importance of medication adherence cannot be overlooked, especially for patients with chronic diseases who require special medications for a long time. Correct medication can not only effectively control the disease and reduce the occurrence of complications, but also significantly reduce medical costs and improve the quality of life of patients. However, the reality is that due to a variety of factors such as drug side effects, complexity of treatment options, financial burden, and misunderstandings about diseases and treatments, many patients find it difficult to strictly adhere to the treatment plan, especially with limited insurance benefits, these problems are lost to patients for self-care, and the result is more waste of medicine
The publication of a randomized clinical trial (RCT) at JAMA identified six types of interventions, including: patient education (e.g., regular individualised telephone consultations); drug dose management (using combination drugs to reduce the number of pills a patient takes per day); Clinical pharmacists negotiate chronic disease co-management (including education, increased frequency of disease surveillance, telephone or in-person follow-up visits, and reminders for follow-up visits); cognitive-behavioral therapy (e.g., motivational interviewing by a trained counselor); medication reminders (e.g., reminder calls for follow-up medication pick-up or real-time monitoring and reminders using electronic medication monitors); and incentives to promote prescriptiveness (e.g., lower drug costs and incentives to patients and clinicians for achieving disease management goals).
The choice of intervention will depend on the practicability of patient management and its availability within the healthcare system. Interventions that have been successful and clinically practical include the use of combination drugs to reduce daily doses, clinical pharmacist co-management, and regular medication reminders, such as telephone reminders to return to refill medications (absolute improvements in adherence observed at 10%、15% , and 33%, respectively)
PATIENTSFORCE has long focused on providing hub services between pharmaceutical companies and medical units, using its self-developed PJM digital management platform, combined with the care services provided by decentralized clinical medical personnel, effectively improving the medical order compliance rate of patients with special drugs (such as cancer or rare diseases or patients with biological agents) to more than 90%, and also providing continuous care services for patients with special medical materials The core of its business is to put patients at the center of care services. This allows for highly personalized treatment and management.
Overall, improving medication adherence is key to improving chronic disease management and patient outcomes. Through integrated support and interventions, patients can not only overcome the challenges of medication compliance, but also further improve their treatment outcomes and quality of life, and optimize the patient service strategy of pharmaceutical providers, so that patients can become the ultimate beneficiary.
Evie Wang, Chief Operating Officer of PATIENTSFORCE Health Integration Group
Cited Data :
https://jamanetwork.com/journals/jama/article-abstract/2718800
